Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03567174 · ClinicalTrials.gov registry record · NA

Building on Needle Exchange to Optimize Prevention & Treatment

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
720
Enrollment target

NCT03567174: Completed NA study, sponsored by Johns Hopkins University.

NCT03567174 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 720 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03567174, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
720 participants
Enrollment target

Study Summary

There are several biomedical interventions that can help people who inject drugs (particularly those with or at risk for HIV), but these services often do not get to the people most in need. In this project investigators propose to determine if delivery of these services to PWID by an integrated care van that is linked to a mobile syringe service program improves clinical outcomes, is feasible and sustainable, and is cost-effective.

Interventions

  • OTHER Integrated care van (ICV)

Trial Details

FieldValue
Enrollment Target 720 participants
Start Date 2018-06-22
Est. Completion 2022-08-02
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03567174

The ClinicalTrials.gov registry entry for NCT03567174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Integrated care van (ICV) is the first listed.

NCT03567174 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03567174 about?

NCT03567174 is a clinical study titled "Building on Needle Exchange to Optimize Prevention & Treatment". There are several biomedical interventions that can help people who inject drugs (particularly those with or at risk for HIV), but these services often do not get to the people most in need. In this project investigators propose to determine if delivery of these services to PWID by an integrated car...

What is the current status of trial NCT03567174?

This trial is currently completed. It is a NA study. The enrollment target is 720 participants. The study started on 2018-06-22. Estimated completion is 2022-08-02.

What interventions are being tested in trial NCT03567174?

The interventions under investigation include: Integrated care van (ICV) (OTHER).

Who is sponsoring clinical trial NCT03567174?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.